A new CME course on molecular breast imaging (MBI) will soon be available through the International Center for Postgraduate Medical Education (ICPME) of Ithaca, NY, as a result of a joint venture by Gamma Medica and GE Healthcare. The one-hour, online session Molecular Breast Imaging (MBI) Clinical Indications, Benefits and Challenges will provide an overview of the emerging technology and its applicability to women with dense breast tissue.
Studies have shown that MBI can prove a useful secondary tool for imaging women with dense breasts, for whom traditional mammography has trouble detecting lesions. Using functional imaging—which can distinguish altered characteristics in breast tissue before anatomical changes take place—MBI can identify lesions as small as 5 mm.
“As the challenges of imaging dense breast tissue become more widely acknowledged, interest in MBI is growing because of its benefits in imaging these women,” said Jim Calandra, CEO of Gamma Medica. “Through courses such as this, Gamma Medica hopes to enhance awareness of MBI in the medical community and promote its use.”
The prerecorded session will be taught by Stephen W. Phillips, MD, medical director of Methodist Sugar Land Hospital Breast Center, assistant professor of radiology at Weill Cornell Medical College, NY, and formerly assistant professor of radiology at Mayo Clinic. Participants can register for the course at the ICPME website.
